| Issue Date | Title | Author(s) |
| 2021-05-30 | Genetic Dominant Variants in STUB1, Segregating in Families with SCA48, Display In Vitro Functional Impairments Indistinctive from Recessive Variants Associated with SCAR16. | Pakdaman, Y; Berland, S; Bustad, HJ; Erdal, S; Thompson, BA; James, PA; Power, KN; Ellingsen, S; Krooni, M; Berge, LI; Sexton, A; Bindoff, LA; Knappskog, PM; Johansson, S; Aukrust, I |
| 2021-05-13 | Dyadic concordance and associations of beliefs with intentions to learn carrier results from genomic sequencing | Huelsnitz, CO; Turbitt, E; Taber, JM; Lewis, KL; Biesecker, LG; Biesecker, BB; Klein, WMP |
| 2021-06-25 | Evaluation of two population screening programmes for <i>BRCA1/2</i> founder mutations in the Australian Jewish community: a protocol paper. | Cousens, NE; Tiller, J; Meiser, B; Barlow-Stewart, K; Rowley, S; Ko, Y-A; Mahale, S; Campbell, IG; Kaur, R; Bankier, A; Burnett, L; Jacobs, C; James, PA; Trainer, A; Neil, S; Delatycki, MB; Andrews, L |
| 2023-06-21 | A survey of genetic and palliative care health professionals' views of integrating genetics into palliative care. | White, S; Turbitt, E; Rogers, K; Tucker, K; McEwen, A; Best, M; Phillips, JL; Jacobs, C |
| 2021-07-22 | The Core Outcome DEvelopment for Carrier Screening (CODECS) study: protocol for development of a core outcome set | Richardson, E; McEwen, A; Newton-John, T; Manera, K; Jacobs, C |
| 2022 | Attitudes of Australian dermatologists on the use of genetic testing: A cross-sectional survey with a focus on melanoma. | Primiero, CA; Baker, AM; Wallingford, CK; Maas, EJ; Yanes, T; Fowles, L; Janda, M; Young, M-A; Nisselle, A; Terrill, B; Lodge, JM; Tiller, JM; Lacaze, P; Andersen, H; McErlean, G; Turbitt, E; Soyer, HP; McInerney-Leo, AM |
| 2020-01-01 | Opportunities for immersive virtual reality in rehabilitation: Focus on communication disability | Bryant, L; Bluff, A; Barnett, D; Hemsley, B; Nguyen, V; Jacobs, C; Power, E; Bailey, B; Stubbs, P; Lucas, C |
| 2023-09-04 | How do women talk about self-funded breast cancer genetic testing?: Small stories and stance-taking strategies. | Bechaz, A; Sexton, A; Gill, G; Karidakis, M |
| 2020-09 | What do we do and how do we do it? Assessing genetic counselling in the modern era. | Yeates, L; McEwen, A; Ingles, J |
| 2021-08 | Parent clinical trial priorities for fragile X syndrome: a best-worst scaling. | Turbitt, E; D'Amanda, C; Hyman, S; Weber, JD; Bridges, JFP; Peay, HL; Biesecker, BB |
